Endoscopic Submucosal Dissection Effective for Rectal Neoplasms

Endoscopic submucosal dissection (ESD) shows promise for safely resecting rectal neoplasms near the dentate line, improving surgical options.

En bloc resection rates reached 93.7% and R0 resection rates were at 85.4% in 255 patients.
Overall adverse events occurred in just 8.7%, with manageable complications like bleeding (5.1%).

This technique could replace traditional transanal methods, but careful patient selection and planning are crucial for optimal outcomes.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.